233 related articles for article (PubMed ID: 22367910)
41. [Modification of natural products for drug discovery].
Guo ZR
Yao Xue Xue Bao; 2012 Feb; 47(2):144-57. PubMed ID: 22512023
[TBL] [Abstract][Full Text] [Related]
42. Hit finding: towards 'smarter' approaches.
Langer T; Hoffmann R; Bryant S; Lesur B
Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
[TBL] [Abstract][Full Text] [Related]
43. Molecular scaffold analysis of natural products databases in the public domain.
Yongye AB; Waddell J; Medina-Franco JL
Chem Biol Drug Des; 2012 Nov; 80(5):717-24. PubMed ID: 22863071
[TBL] [Abstract][Full Text] [Related]
44. From retrospective assessment to prospective decisions in natural product isolation: HPLC-SPE-NMR analysis of Carthamus oxyacantha.
Johansen KT; Wubshet SG; Nyberg NT; Jaroszewski JW
J Nat Prod; 2011 Nov; 74(11):2454-61. PubMed ID: 22060189
[TBL] [Abstract][Full Text] [Related]
45. Ligand specificity, privileged substructures and protein druggability from fragment-based screening.
Barelier S; Krimm I
Curr Opin Chem Biol; 2011 Aug; 15(4):469-74. PubMed ID: 21411360
[TBL] [Abstract][Full Text] [Related]
46. The evolving role of natural products in drug discovery.
Koehn FE; Carter GT
Nat Rev Drug Discov; 2005 Mar; 4(3):206-20. PubMed ID: 15729362
[TBL] [Abstract][Full Text] [Related]
47. Medicinal chemistry inspired fragment-based drug discovery.
Lanter J; Zhang X; Sui Z
Methods Enzymol; 2011; 493():421-45. PubMed ID: 21371600
[TBL] [Abstract][Full Text] [Related]
48. A screening pattern recognition method finds new and divergent targets for drugs and natural products.
Wassermann AM; Lounkine E; Urban L; Whitebread S; Chen S; Hughes K; Guo H; Kutlina E; Fekete A; Klumpp M; Glick M
ACS Chem Biol; 2014 Jul; 9(7):1622-31. PubMed ID: 24802392
[TBL] [Abstract][Full Text] [Related]
49. Analytical profiling of bioactive constituents from herbal products, using metabolomics--a review.
Satheeshkumar N; Nisha N; Sonali N; Nirmal J; Jain GK; Spandana V
Nat Prod Commun; 2012 Aug; 7(8):1111-5. PubMed ID: 22978242
[TBL] [Abstract][Full Text] [Related]
50. Innovative omics-based approaches for prioritisation and targeted isolation of natural products - new strategies for drug discovery.
Wolfender JL; Litaudon M; Touboul D; Queiroz EF
Nat Prod Rep; 2019 Jun; 36(6):855-868. PubMed ID: 31073562
[TBL] [Abstract][Full Text] [Related]
51. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
52. Isolation of microbial natural products.
Sterner O
Methods Mol Biol; 2012; 864():393-413. PubMed ID: 22367905
[TBL] [Abstract][Full Text] [Related]
53. [The discovery process in the pharmaceutical industry].
Scatton B
J Soc Biol; 2009; 203(3):249-69. PubMed ID: 19833071
[TBL] [Abstract][Full Text] [Related]
54. Initial and bulk extraction of natural products isolation.
Seidel V
Methods Mol Biol; 2012; 864():27-41. PubMed ID: 22367892
[TBL] [Abstract][Full Text] [Related]
55. Herbal bioactive molecules: the hidden jewels for drug development. Introduction.
Fred Wong W
Clin Exp Pharmacol Physiol; 2012 Mar; 39(3):253-5. PubMed ID: 22309246
[No Abstract] [Full Text] [Related]
56. Lessons from natural products chemistry can offer novel approaches for synthetic chemistry in drug discovery.
Vasilevich NI; Kombarov RV; Genis DV; Kirpichenok MA
J Med Chem; 2012 Aug; 55(16):7003-9. PubMed ID: 22712563
[No Abstract] [Full Text] [Related]
57. Drug discovery and natural products: end of an era or an endless frontier?
Li JW; Vederas JC
Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
[TBL] [Abstract][Full Text] [Related]
58. Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database.
Nikolovska-Coleska Z; Xu L; Hu Z; Tomita Y; Li P; Roller PP; Wang R; Fang X; Guo R; Zhang M; Lippman ME; Yang D; Wang S
J Med Chem; 2004 May; 47(10):2430-40. PubMed ID: 15115387
[TBL] [Abstract][Full Text] [Related]
59. The benefits of constructing leads from fragment hits.
Foloppe N
Future Med Chem; 2011 Jul; 3(9):1111-5. PubMed ID: 21806375
[TBL] [Abstract][Full Text] [Related]
60. Identification of human IKK-2 inhibitors of natural origin (Part II): in Silico prediction of IKK-2 inhibitors in natural extracts with known anti-inflammatory activity.
Sala E; Guasch L; Iwaszkiewicz J; Mulero M; Salvadó MJ; Bladé C; Ceballos M; Valls C; Zoete V; Grosdidier A; Garcia-Vallvé S; Michielin O; Pujadas G
Eur J Med Chem; 2011 Dec; 46(12):6098-103. PubMed ID: 22000921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
